Metastasis, the epitome of cancer progression, is a pathophysical process of profound significance, because much of the lethality from malignant neoplasms is attributed directly to their ability to develop metastasis in distant organs. Carbohydrate-mediated recognition leads to the formation of multi-cell emboli in the circulation, a process directly related to the development of metastases. The role of galectin-3 in this process is now established through the efforts of this continued research. Galectin-3 is a member of the galectin gene family, composed of at least twelve members. Galectin-3 is a chimeric gene product with monomer subunit of about 30,000 daltons, composed of three distinct structural motifs, a short NH2-origin preceding an amino half-domain containing Gly-X-Y tandem repeats characteristic of collagens and carboxy-terminal half which encompasses the N-acetyllactosamine (Galbeta-4GlcNac)-binding site. Galectin-3 is an unusual protein, in that it is localized and functions in the cytoplasm, cell membrane, nucleus and the extracellular milieu and undergoes for function a non-covalent homodimerization and post-translation phosphorylation that regulate carbohydrate-recognition. It contains the NWGR anti-death motif of the BH1 domain of the bcl-2 family members. Galectin-3 has distinct functions and recognition sites involving different cell lineages at different developmental and pathological stages including cell growth, apoptosis-resistance, adhesion, differentiation, inflammation, transformation, angiogenesis, invasion and metastasis. We now propose to define in greater detail the structural-functional relationship of galectin-3 as it relates to cellular localization, cell growth, apoptosis-resistance, cell-cell recognition, angiogenesis, tumor growth and hematogenous spread of tumor cells. To this end we propose the following: 1) To determine the molecular basis of the anti-apoptotic property of galectin-3; 2) To determine the functional consequence of galectin-3 phosphorylation on cell regulation and apoptosis; 3) To study the effect of antigalectin-3 therapy on cancer progression and metastasis. It is expected that the results to be obtained from this study will provide a better understanding of galectin-3 and its interacting ligands in tumor progression and metastasis and will further the developments of specific reagents for the detection and interventions in these processes.
Showing the most recent 10 out of 56 publications
